The Role of Nomogram Based on the Combination of Ultrasound Parameters and Clinical Indicators in the Degree of Pathological Remission of Breast Cancer

Table 1

Basic demographic data of patients.

Demographic indicators		NMHR (n = 93)	MHR (n = 54)
Age (years)		57.0 (49.0, 63.5)	52.5 (48.0, 57.0)	0.009
Whether menopause	No	49 (52.7)	33 (61.1)	0.322
	Yes	44 (47.3)	21 (38.9)
History of birth and lactation	No	6 (6.5)	0 (0.0)	0.141
	Yes	87 (93.5)	54 (100.0)
Family history	No	91 (97.8)	54 (100.0)	0.278
	Yes	2 (2.2)	0 (0.0)
Lymph node metastasis	No	22 (23.9)	14 (25.9)	0.785
	Yes	70 (76.1)	40 (74.1)
Period of treatment	<6 issues	39 (41.9)	12(22.2)	0.015
	≥6 periods	54 (58.1)	42 (77.8)
Program	TAC	47 (50.5)	20 (37.0)	<0.001
	TCbHP	2 (2.2)	13 (24.1)
	AT	11 (11.8)	8 (14.8)
	TP	4 (4.3)	5 (9.3)
	AC	8 (8.6)	1 (1.9)
	TC	21 (22.6)	7 (13.0)
Pathological type	Catheter	80 (86.0)	45 (83.3)	0.728
	Leaflet	6 (6.5)	3 (5.6)
	Myeloid	4 (4.3)	2 (3.7)
	Unknown	3 (3.2)	4 (7.4)
ER	Feminine	32 (35.2)	39 (75.0)	<0.001
	Positive	59 (64.8)	13 (25.0)
PR	Feminine	51 (56.0)	46 (88.5)	<0.001
	Positive	40 (44.0)	6 (11.5)
CerbB-2	Feminine	7 (7.6)	3 (5.6)	0.893
	Positive	85 (92.4)	51 (94.4)
Ki67	Feminine	20 (22.2)	3 (5.8)	0.010
	Positive	70 (77.8)	49 (94.2)